Is Aurinia Pharmaceuticals Inc. (AUPH) A Good Stock To Buy Now?

Is AUPH a good stock to buy? We came across a bullish thesis on Aurinia Pharmaceuticals Inc. on BioEquity Watch’s Substack. In this article, we will summarize the bulls’ thesis on AUPH. Aurinia Pharmaceuticals Inc.’s share was trading at $18.62 as of June 24th. AUPH’s trailing and forward P/E were 8.27 and 23.42 respectively according to Yahoo Finance.

27 Largest Biotech Companies in the US

Pressmaster/Shutterstock.com

Aurinia Pharmaceuticals Inc., a biopharmaceutical company, engages in delivering therapies to people...